The MCAO procedure did not evoke any significant changes in the CD86 expression; however, in the group treated with AP39 and subjected to ischemia, a reduced CD86 expression was observed in the frontal cortex and in the dorsal striatum (p = 0.048 and p = 0.016, respectively) (Figure 6). Here, CD86 is linked to ischemia.